NCT01931527View on ClinicalTrials.gov

Effect of Reducing Uric Acid on Insulin Sensitivity and Oxidative Status

NACompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

June 30, 2008

Study Completion Date

November 30, 2012

Conditions
ObesityMetabolic SyndromeHyperuricemia
Interventions
DRUG

Rasburicase

one single infusion of rasburicase (0.19 mg/kg FFM) infused over 30 min

Trial Locations (1)

63110

Washington University School of Medicine, St Louis

All Listed Sponsors
lead

Washington University School of Medicine

OTHER

NCT01931527 - Effect of Reducing Uric Acid on Insulin Sensitivity and Oxidative Status | Biotech Hunter | Biotech Hunter